Ketamine, MDMA, DMT and psilocybin are four psychedelics that are making waves in psychiatric medicine. While they are all banned or restricted in the industrialized west, these compounds have moved past decades of stigma to become well-studied therapeutics either approved or in trial to treat mental health conditions such as major depression and post-traumatic stress disorder.

Download this listicle to learn:

• The backgrounds of these psychedelics
• Their properties and potential mechanisms of action
• The conditions that they could help treat